LH Laboratory Corporation of America Holdings

$253.12

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 1/6/2026

About Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings, more commonly known as Labcorp, is an American company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks in the world, with a United States network of 36 primary laboratories.

Website: https://www.labcorp.com

Sector
LIFE SCIENCES
Industry
SERVICES-MEDICAL LABORATORIES
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
920148
Address
358 S MAIN ST, BURLINGTON, NC, US
Valuation
Market Cap
$18.17B
P/E Ratio
24.56
PEG Ratio
0.79
Price to Book
2.26
Performance
EPS
$8.84
Dividend Yield
1.33%
Profit Margin
5.74%
ROE
9.36%
Technicals
50D MA
$239.04
200D MA
$230.18
52W High
$258.59
52W Low
$190.25
Fundamentals
Shares Outstanding
84M
Target Price
$270.51
Beta
0.97

LH EPS Estimates vs Actual

Estimated
Actual

LH News & Sentiment

Dec 31, 2025 • MarketBeat SOMEWHAT-BULLISH
Allspring Global Investments Holdings LLC Lowers Stake in Labcorp Holdings Inc. $LH
Allspring Global Investments Holdings LLC reduced its stake in Labcorp Holdings Inc. by 0.2% in the third quarter, while still holding a significant position. Insiders, including Director Richelle P. Parham and CEO Adam H. Schechter, also sold shares, decreasing insider ownership to about 0.84%. Labcorp exceeded Q3 EPS estimates, saw an 8.6% increase in revenue, and set strong FY2025 guidance, with analysts maintaining a "Moderate Buy" rating and a consensus target price of nearly $299.
Dec 31, 2025 • BioSpace SOMEWHAT-BULLISH
Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Labcorp (NYSE: LH) announced its participation in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, at 4:30 p.m. PT. A live audio webcast will be available on the company's Investor Relations website. Labcorp is a global leader in laboratory services, providing diagnostics and drug development capabilities to clients in approximately 100 countries.
Dec 30, 2025 • Finviz NEUTRAL
Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Labcorp announced its participation in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, at 4:30 p.m. PT. A live audio webcast will be available on the company's investor relations website. Labcorp, a global leader in laboratory services, provides diagnostics and drug development capabilities, serving clients in approximately 100 countries.
Dec 30, 2025 • TipRanks SOMEWHAT-BULLISH
Labcorp to Present at J.P. Morgan Healthcare Conference
Labcorp Holdings will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026. This presentation aims to engage with the investment community regarding Labcorp's diagnostics and drug development contributions. Analysts currently rate LH stock as a Buy with a $308.00 price target, and TipRanks’ AI Analyst, Spark, also provides an "Outperform" rating, indicating a positive outlook despite some bearish technical indicators.
Dec 30, 2025 • TradingView — Track All Markets NEUTRAL
Labcorp Holdings Inc to Participate in J.P. Morgan Healthcare Conference
Labcorp Holdings Inc (LH) announced its participation in the 44th Annual J.P. Morgan Healthcare Conference. The company will join a fireside chat on January 13, 2025, which will be webcast live on Labcorp's Investor Relations site and subsequently archived for replay. This announcement was made via an SEC filing on December 30, 2025.
Dec 30, 2025 • WV News NEUTRAL
Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Labcorp (NYSE: LH) announced its participation in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference. The event is scheduled for Tuesday, January 13, at 4:30 p.m. PT, and a live audio webcast will be available on Labcorp's Investor Relations website. The company is a global leader in laboratory services, supporting healthcare decisions and drug development.
Sentiment Snapshot

Average Sentiment Score:

0.119
51 articles with scored sentiment

Overall Sentiment:

Neutral

LH Reported Earnings

Jul 24, 2025
Jun 30, 2025 (Pre market)
0.19 Surprise
  • Reported EPS: $4.35
  • Estimate: $4.16
  • Whisper:
  • Surprise %: 4.6%
Apr 29, 2025
Mar 31, 2025 (Pre market)
0.11 Surprise
  • Reported EPS: $3.84
  • Estimate: $3.73
  • Whisper:
  • Surprise %: 3.0%
Feb 06, 2025
Dec 31, 2024 (Pre market)
0.06 Surprise
  • Reported EPS: $3.45
  • Estimate: $3.39
  • Whisper:
  • Surprise %: 1.8%
Oct 24, 2024
Sep 30, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $3.50
  • Estimate: $3.49
  • Whisper:
  • Surprise %: 0.3%
Aug 01, 2024
Jun 30, 2024 (Pre market)
0.14 Surprise
  • Reported EPS: $3.94
  • Estimate: $3.80
  • Whisper:
  • Surprise %: 3.7%
Apr 25, 2024
Mar 31, 2024 (Pre market)
0.2 Surprise
  • Reported EPS: $3.68
  • Estimate: $3.48
  • Whisper:
  • Surprise %: 5.8%
Feb 15, 2024
Dec 31, 2023 (Pre market)
0.04 Surprise
  • Reported EPS: $3.30
  • Estimate: $3.26
  • Whisper:
  • Surprise %: 1.2%
Oct 26, 2023
Sep 30, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $3.38
  • Estimate: $3.33
  • Whisper:
  • Surprise %: 1.5%
Jul 27, 2023
Jun 30, 2023 (Pre market)
0.27 Surprise
  • Reported EPS: $3.80
  • Estimate: $3.53
  • Whisper:
  • Surprise %: 7.7%

Financials